Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-11-21 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
关于参加“重庆辖区2024年投资者网上集体接待日活动”的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement about the company's participation in an investor online reception day event, including details about the date, time, and platform for investor communication. It does not contain financial data, report content, or voting results. It is not a report, transcript, or regulatory filing of financial results. It is an announcement related to investor relations activities, but not a formal investor presentation or report. Given the short length and nature, it fits best as a Regulatory Filing (RNS) as a general announcement that does not fit other categories.
2024-11-21 Chinese
关于2024年度为合作养殖农户提供担保预计的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tianyu Biological Technology Co., Ltd. regarding the progress of guarantees provided to cooperative farming households for the year 2024. It details the guarantee amounts, the parties involved, internal decision procedures, and the rationale for the guarantees. The document is relatively short (2410 characters) and focuses on a specific financial guarantee update rather than comprehensive financial results or management discussion. It does not contain financial statements or detailed financial analysis. It is not a report like an Annual Report or Interim Report, nor is it a call transcript or earnings release. It is a regulatory announcement about a specific financing-related guarantee activity. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-11-13 Chinese
2024年第五次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 fifth extraordinary general meeting of shareholders of Tianyu Bio-Technology Co., Ltd. It includes information about the meeting date, location, attendance, voting results, and legal witness statements. The content focuses on the official results of shareholder votes on specific proposals, including related party transactions. There is no indication that this is a full annual or interim report, audit report, or other financial report. The document is not a proxy solicitation or presentation but an official announcement of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 1666 characters, which is consistent with an announcement rather than a full report. Confidence is high due to the clear presence of voting results and meeting details.
2024-10-31 Chinese
北京盈科（上海）律师事务所关于天域生物科技股份有限公司2024年第五次临时股东大会之法律意见书
Regulatory Filings
2024-10-31 Chinese
舆情管理制度
Governance Information Classification · 95% confidence The document is titled '舆情管理制度' which translates to 'Public Opinion Management System' or 'Crisis Management Policy'. It outlines the company's internal policies and procedures for managing public opinion, media reports, rumors, and information that could affect the company's stock price and reputation. It includes organizational structure, responsibilities, principles, and legal responsibilities related to managing public opinion. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no management changes, no capital updates, no earnings information, or any other typical financial or regulatory report content. The document is a governance-related internal policy document describing the company's approach to managing public relations and information disclosure risks. Therefore, it best fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3008 characters, which is relatively short but contains substantive policy content rather than a mere announcement. Hence, the classification is CGR with high confidence.
2024-10-30 Chinese
关于继续开展商品期货套期保值业务的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Tianyu Biological Technology Co., Ltd. regarding the continuation of commodity futures hedging business. It details the purpose, scope, risk analysis, risk control measures, and accounting treatment related to the hedging activities. The document is relatively short (3053 characters) and serves as a formal disclosure of a business activity decision and risk management, not a financial report or earnings release. It does not contain financial statements or detailed financial data. It is not a report publication announcement since it contains substantive information about the hedging business. The content fits best under a general regulatory announcement category about business operations and risk disclosures, which aligns with Regulatory Filings (RNS).
2024-10-30 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.